Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ford

Showing results (741-750 of 1,828) with videos related to

Pageof 183
Sort By:
Alimentary Pharmacology & Therapeutics|March 9, 2025
Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow-UpChristy Riggott, Keeley M Fairbrass, David J Gracie, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 16, 2024
Reducing uncertainty in dose-response assessments by incorporating Bayesian benchmark dose modeling and in vitro data on population variabilityEn-Hsuan Lu, Lucie C Ford, Ivan Rusyn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 25, 2023
Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysisBrigida Barberio, David J Gracie, Christopher J Black, et al.
Diabetes|April 6, 2001
Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracersN Moller, R A Rizza, G C Ford, et al.
The Cochrane Database of Systematic Reviews|October 13, 2009
WITHDRAWN: Initial management strategies for dyspepsiaBrendan Delaney, Alex C Ford, David Forman, et al.
The American Journal of Gastroenterology|November 24, 2011
Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysisAlexander C Ford, Khurram J Khan, Jean-Paul Achkar, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 7, 2000
Histologic estimation of coronary artery stenoses: reproducibility and the effect of trainingJ C Ford, K O'Rourke, J P Veinot, et al.
The Biochemical Journal|October 15, 1996
Structural changes in photosystem II after treatment with the zero-length bifunctional cross-linker 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide: an electron microscopic studyR F Collins, T D Flint, A Holzenburg, et al.
The British Journal of Surgery|July 1, 1990
Influence of glucagon on protein and leucine metabolism: a study in fasting man with induced insulin resistanceP J Pacy, K N Cheng, G C Ford, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 23, 2021
Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysisBrigida Barberio, Edoardo Vincenzo Savarino, Christopher J Black, et al.
Pageof 183

Showing results (741-750 of 1,828) with videos related to

Sort By:
Pageof 183
Alimentary Pharmacology & Therapeutics|March 9, 2025
Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow-UpChristy Riggott, Keeley M Fairbrass, David J Gracie, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|August 16, 2024
Reducing uncertainty in dose-response assessments by incorporating Bayesian benchmark dose modeling and in vitro data on population variabilityEn-Hsuan Lu, Lucie C Ford, Ivan Rusyn, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 25, 2023
Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysisBrigida Barberio, David J Gracie, Christopher J Black, et al.
Diabetes|April 6, 2001
Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracersN Moller, R A Rizza, G C Ford, et al.
The Cochrane Database of Systematic Reviews|October 13, 2009
WITHDRAWN: Initial management strategies for dyspepsiaBrendan Delaney, Alex C Ford, David Forman, et al.
The American Journal of Gastroenterology|November 24, 2011
Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysisAlexander C Ford, Khurram J Khan, Jean-Paul Achkar, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|November 7, 2000
Histologic estimation of coronary artery stenoses: reproducibility and the effect of trainingJ C Ford, K O'Rourke, J P Veinot, et al.
The Biochemical Journal|October 15, 1996
Structural changes in photosystem II after treatment with the zero-length bifunctional cross-linker 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide: an electron microscopic studyR F Collins, T D Flint, A Holzenburg, et al.
The British Journal of Surgery|July 1, 1990
Influence of glucagon on protein and leucine metabolism: a study in fasting man with induced insulin resistanceP J Pacy, K N Cheng, G C Ford, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 23, 2021
Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysisBrigida Barberio, Edoardo Vincenzo Savarino, Christopher J Black, et al.
Pageof 183